News
-
-
PRESS RELEASE
Amoéba obtains an exceptional exemption in the Netherlands for its biocontrol product AXPERA for large-scale greenhouse trials
Amoéba obtained authorisation for trials of AXPERA in the Netherlands, allowing consumption of treated crops. The Dutch greenhouse market is a strategic showcase for showcasing AXPERA's value in biocontrol fungicide -
-
PRESS RELEASE
New strategic milestone for Amoéba: Axpéra biocontrol product receives emergency market authorisation in France // A proven new solution to help winegrowers combat grapevine downy mildew
Amoéba receives emergency marketing authorization for AXPERA biocontrol product to combat grapevine downy mildew, helping French winegrowers against phytosanitary challenges -
-
-
-
PRESS RELEASE
Amoéba announces a second initiation of coverage by KBC Securities and confirms its new international dimension
Amoéba, the green tech company, sees KBC Securities initiate stock coverage with Buy recommendation & target price. Company focused on microbiological solutions & expanding investor base -
-
PRESS RELEASE
Amoéba signs a Memorandum of Understanding with Metron Technology, a subsidiary of the Oriental Beauty Valley (OBV) group, the undisputed leader in cosmetics in China
Amoéba signs MoU with Oriental Beauty Valley group for registration of natural cosmetic ingredient in China, showcasing global interest in their solutions. Potential in innovation and sustainability highlighted
